
Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | United States | 2023–2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market, Introducer Sheath Market, and 12 more
- Year: 2023
- Scope: 10 Years
- Region: United States
- Pages: 442
- Published Date: 01/06/2023
- Type: MedSuite
In 2022, the U.S. interventional cardiology device market size was valued at approximately $3.9 billion in 2022. Over the forecast, the market size is expected to increase to reach $4.8 billion by 2029.
The full report suite on the U.S. market for interventional cardiology devices includes coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPD), coronary atherectomy and intravascular lithotripsy devices, coronary thrombectomy devices, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCD), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT) and hemostasis valves.
Throughout this medical market research, we analyzed 43 interventional cardiology device companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Procedure Volumes for the Interventional Cardiology Devices
- Market Forecasts Until 2029, and Historical Data to 2019
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Interventional Cardiology Device Market
- Recent Mergers & Acquisitions
- COVID19 Impact on the Interventional Cardiology Device Market in the US
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
PROCEDURE NUMBERS
Coronary artery disease (CAD) is a multifaceted disease that yields various approaches in terms of diagnosis and treatment options. The most commonly performed procedure within the interventional cardiology space is angiography. Angiography remains the gold standard for diagnostic coronary procedures. This report also analyzes angioplasty (or PCI) procedures, Coronary Total Occlusion (CTO) and coronary atherectomy procedures.
U.S. Interventional Cardiology Market Insights
Demographics are still playing a positive role in the market as the population both ages and increases in size. According to the American Heart Association, about 6.7% of all American adults have cardiac artery disease (CAD). Because cardiovascular disease tends to be much more prevalent as a person ages, these two factors are contributing to an overall increase in procedure numbers and potential patients.
U.S. Interventional Cardiology Market Share Insights
The U.S. Interventional Cardiology device market was controlled by Boston Scientific, Abbott, and Medtronic.
Boston Scientific is an extremely well-established competitor in the interventional cardiology field, with a strong reputation and large sales force in both the coronary and peripheral markets. The company has recently emphasized its focus on the complex Percutaneous Coronary Intervention (PCI) opportunity in the market, for which it offers specialized devices, such as CTO systems, atherectomy devices, specialty balloon catheters, embolic protection devices, IVUS and Fractional Flow Reserve (FFR).
Detailed Market Segmentation
- Coronary Stent Market – MedCore – The market is further broken down into segments by:
- Device Type: Bare-Metal Stents, Drug-Eluting Stents, Covered Stents, and Bifurcated Stents;
- Units Size: Length and Diameter.
- Coronary Balloon Catheter Market – MedCore – The market is also further segmented by:
- Device Type: PTCA Balloon and Specialty Balloon (Cutting/Scoring);
- Classification: Compliant, Semi-Compliant, and Non-Compliant;
- Indication: Pre-Dilation & Stent Placement, and Post-Dilation.
- Introducer Sheath Market – MedCore – The chapter contains the market analysis which is categorized by:
- Device Type: Standard Introducer and Micro-Introducer Sheaths;
- Approach: Femoral and Radial.
- Balloon-Inflation Device Market – MedCore – In-depth analysis of the Balloon-Inflation Device market.
- Interventional Coronary Catheter Market – MedCore – This market and its analysis is categorized into Guiding Catheters, Extension Guide Catheters, and Micro-Catheters.
- Interventional Coronary Guidewire Market – MedCore – In-depth analysis of the Interventional Coronary Guidewire market.
- Coronary Embolic Protection Device Market – MedCore – In-depth analysis of the Coronary Embolic Protection Device market.
- Coronary Atherectomy Device Market – MedCore – The market is further broken down into Mechanical Atherectomy and Laser Atherectomy devices.
- Coronary Thrombectomy Market – MedCore – In-depth analysis of the Coronary Thrombectomy market.
- Coronary Chronic Total Occlusion (CTO) System Market – MedCore – This market consists of the segments for the CTO Guidewires, CTO Catheters, and CTO Devices.
- Coronary Vascular Closure Device (VCD) Market – MedCore – The market analysis includes the segments, such as Invasive and Non-Invasive VCDs (Topical Hemostats/Radial Compression Bands/Femoral Compression Bands).
- Diagnostic Coronary Catheter & Guidewire Market – MedCore – The chapter takes a closer look at the different market segments, including Diagnostic Catheter, Diagnostic Guidewire, and FFR Guidewire markets.
- Coronary Intravascular Ultrasound (IVUS) Market – MedCore – The market is further broken down into segments based on the Device Type into IVUS Catheters and IVUS Consoles.
- Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market.
- Hemostasis Valve Market – MedCore – In-depth analysis of the Hemostasis Valve market.
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Region | North America (United States) |
Base Year | 2022 |
Forecast | 2023-2029 |
Historical Data | 2019-2022 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
\WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
TABLE of CONTENTS |
List of Figures |
List of Charts |
executive summary |
U.S. Interventional Cardiology Device Market Overview |
Competitive Analysis |
Market Trends |
Market Developments |
Procedure Numbers |
Procedure Codes Investigated |
Markets Included |
Key Report Updates |
Version History |
research methodology |
Step 1: Project Initiation & Team Selection |
Step 2: Prepare Data Systems and Perform Secondary Research |
Step 3: Preparation for Interviews & Questionnaire Design |
Step 4: Performing Primary Research |
Step 5: Research Analysis: Establishing Baseline Estimates |
Step 6: Market Forecast and Analysis |
Step 7: Identify Strategic Opportunities |
Step 8: Final Review and Market Release |
Step 9: Customer Feedback and Market Monitoring |
impact of COVID-19 on THE U.S. Interventional Cardiology Device Market |
2.1 Introduction |
2.2 Analysis By Market Segment |
2.2.1 Worst Case Scenario |
2.2.2 Base Case Scenario |
2.2.3 Best Case Scenario |
Disease Overview |
Product Assessment |
4.1 Introduction |
4.2 Product Portfolios |
4.3 Regulatory Issues and Recalls |
4.4 Clinical Trials |
U.S. Interventional Cardiology Device Market Overview |
5.1 Introduction |
5.1.1 Population at Risk |
5.2 Market Overview & Trend Analysis |
5.3 Drivers and Limiters |
5.3.1 Market Drivers |
5.3.2 Market Limiters |
5.4 Competitive Market Share Analysis |
5.5 Mergers and Acquisitions |
5.6 Company Profiles |
5.7 SWOT Analysis |
Procedure Numbers |
6.1 Introduction |
6.2 Procedures |
6.2.1 Angiography Procedures |
6.2.1.1 Angiography Procedures by Approach |
6.2.1.2 Angiography Procedures by Setting |
6.2.2 Angioplasty/PCI Procedures |
6.2.2.1 Angioplasty/PCI Procedures by Approach |
6.2.2.2 Angioplasty/PCI Procedures by Modality |
6.2.2.3 Angioplasty/PCI Procedures by Setting |
6.2.2.4 Angioplasty/PCI Procedures by Imaging Technique |
6.2.3 Coronary Atherectomy Procedures |
6.2.4 Coronary Chronic Total Occlusion (CTO) Procedures |
6.2.5 Catheterization Procedures |
Coronary Stent Market |
7.1 Introduction |
7.2 Market Overview |
7.3 Market Analysis and Forecast |
7.3.1 Coronary Stent Market |
7.3.2 Bare-Metal Stent Market |
7.3.3 Drug-Eluting Stent Market |
7.3.4 Covered Stent Market |
7.3.5 Bifurcated Stent Market |
7.4 Unit Analysis |
7.4.1 Coronary Stent Units Sold by Diameter |
7.4.2 Coronary Stent Units Sold by Length |
7.5 Drivers and Limiters |
7.5.1 Market Drivers |
7.5.2 Market Limiters |
7.6 Competitive Market Share Analysis |
Coronary Balloon Catheter Market |
8.1 Introduction |
8.2 Market Overview |
8.3 Market Analysis and Forecast |
8.3.1 Coronary Balloon Catheter Market |
8.3.2 PTCA Balloon Catheter Market |
8.3.3 Specialty Balloon Catheter Market |
8.3.3.1 Cutting Balloon Catheter Market |
8.3.3.2 Scoring Balloon Catheter Market |
8.3.3.3 Drug-Eluting Balloon Catheter Market |
8.4 Unit Analysis |
8.4.1 Coronary Balloon Catheter Units Sold by Classification |
8.4.2 Coronary Balloon Catheter Units Sold by Indication |
8.5 Drivers and Limiters |
8.5.1 Market Drivers |
8.5.2 Market Limiters |
8.6 Competitive Market Share Analysis |
Balloon-Inflation Device Market |
9.1 Introduction |
9.2 Market Analysis and Forecast |
9.3 Drivers and Limiters |
9.3.1 Market Drivers |
9.3.2 Market Limiters |
9.4 Competitive Market Share Analysis |
Interventional Coronary Catheter Market |
10.1 Introduction |
10.2 Market Overview |
10.3 Market Analysis and Forecast |
10.3.1 Interventional Coronary Catheter Market |
10.3.2 Guiding Catheter Market |
10.3.3 Extension Guide Catheter Market |
10.3.4 Microcatheter Market |
10.3.4.1 Traditional Coronary Microcatheter Market |
10.3.4.1.1 Torquable Traditional Coronary Microcatheter Market |
10.3.4.1.2 Braided Traditional Coronary Microcatheter Market |
10.3.4.2 Dual-Lumen Specialty Coronary Microcatheter Market |
10.4 Drivers and Limiters |
10.4.1 Market Drivers |
10.4.2 Market Limiters |
10.5 Competitive Market Share Analysis |
Interventional Coronary Guidewire Market |
11.1 Introduction |
11.1.1 Device Construction |
11.2 Market Analysis and Forecast |
11.3 Drivers and Limiters |
11.3.1 Market Drivers |
11.3.2 Market Limiters |
11.4 Competitive Market Share Analysis |
Coronary Embolic Protection Device Market |
12.1 Introduction |
12.1.1 Saphenous Vein Grafts |
12.1.2 Protection Mechanism |
12.1.2.1 Filter Basket |
12.1.2.2 Distal Balloon Occlusion |
12.2 Market Analysis and Forecast |
12.3 Drivers and Limiters |
12.3.1 Market Drivers |
12.3.2 Market Limiters |
12.4 Competitive Market Share Analysis |
Coronary Atherectomy Device Market |
13.1 Introduction |
13.1.1 Device Technologies |
13.1.1.1 Mechanical Atherectomy |
13.1.1.2 Laser Atherectomy |
13.1.1.3 Directional Coronary Atherectomy (DCA) |
13.2 Market Overview |
13.3 Market Analysis and Forecast |
13.3.1 Coronary Atherectomy Device Market |
13.3.2 Mechanical Atherectomy Device Market |
13.3.3 Laser Atherectomy Device Market |
13.4 Drivers and Limiters |
13.4.1 Market Drivers |
13.4.2 Market Limiters |
13.5 Competitive Market Share Analysis |
Coronary Thrombectomy Device Market |
14.1 Introduction |
14.1.1 Drug-Eluting Stents and Thrombosis Treatment |
14.2 Market Analysis and Forecast |
14.3 Drivers and Limiters |
14.3.1 Market Drivers |
14.3.2 Market Limiters |
14.4 Competitive Market Share Analysis |
Coronary Chronic Total Occlusion System Market |
15.1 Introduction |
15.2 Market Overview |
15.3 Market Analysis and Forecast |
15.3.1 CTO Guidewire Market |
15.3.2 CTO Catheter Market |
15.3.3 CTO Device Market |
15.4 Drivers and Limiters |
15.4.1 Market Drivers |
15.4.2 Market Limiters |
15.5 Competitive Market Share Analysis |
Introducer Sheath Market |
16.1 Introduction |
16.2 Market Overview |
16.3 Market Analysis and Forecast |
16.3.1 Introducer Sheath Market |
16.3.2 Standard Introducer Sheath Market |
16.3.3 Micro-Introducer Sheath Market |
16.4 Introducer Sheaths by Approach |
16.4.1 Femoral Introducer Sheath Market |
16.4.2 Radial Introducer Sheath Market |
16.5 Drivers and Limiters |
16.5.1 Market Drivers |
16.5.2 Market Limiters |
16.6 Competitive Market Share Analysis |
Coronary Vascular Closure Device Market |
17.1 Introduction |
17.1.1 Invasive and Non-Invasive Devices |
17.2 Market Overview |
17.3 Market Analysis and Forecast |
17.3.1 Total Coronary Vascular Closure Device Market |
17.3.2 Invasive VCD Market |
17.3.3 Non-Invasive VCD Market |
17.3.3.1 Topical Hemostat |
17.3.3.2 Radial Compression Band |
17.3.3.3 Femoral Compression |
17.4 Drivers and Limiters |
17.4.1 Market Drivers |
17.4.2 Market Limiters |
17.5 Competitive Market Share Analysis |
Diagnostic Coronary Catheter & Guidewire Market |
18.1 Introduction |
18.2 Market Overview |
18.3 Market Analysis and Forecast |
18.3.1 Diagnostic Coronary Guidewire Market |
18.3.2 Diagnostic Coronary Catheter Market |
18.3.3 FFR Guidewire Market |
18.3.3.1 Fractional Flow Reserve Guidewire Penetration Rate |
18.4 Drivers and Limiters |
18.4.1 Market Drivers |
18.4.2 Market Limiters |
18.5 Competitive Market Share Analysis |
Coronary Intravascular Ultrasound Market |
19.1 Introduction |
19.1.1 Pre-Stenting Applications |
19.1.2 Post-Stenting Applications |
19.1.3 IVUS Penetration |
19.2 Market Overview |
19.3 Market Analysis and Forecast |
19.3.1 IVUS Catheter Market |
19.3.2 IVUS Console Market |
19.4 Drivers and Limiters |
19.4.1 Market Drivers |
19.4.2 Market Limiters |
19.5 Competitive Market Share Analysis |
Coronary Optical Coherence Tomography Market |
20.1 Introduction |
20.2 Market Overview |
20.3 Market Analysis and Forecast |
20.3.1 OCT Catheter Market |
20.3.2 OCT Console Market |
20.4 Drivers and Limiters |
20.4.1 Market Drivers |
20.4.2 Market Limiters |
20.5 Competitive Market Share Analysis |
Hemostasis Valve Market |
21.1 Introduction |
21.2 Market Analysis and Forecast |
21.3 Drivers and Limiters |
21.3.1 Market Drivers |
21.3.2 Market Limiters |
21.4 Competitive Market Share Analysis |
Abbreviations |
Companies Included:
· Abbott | · Infraredx |
· ACIST | · InnoTherapy |
· Acrostak | · Marine Polymer Technologies |
· Advanced Vascular Dynamics | · MedAlliance |
· AngioDynamics | · Medtronic |
· Argon Medical | · Merit Medical Systems |
· Asahi Intecc | · Morris Innovative |
· Avinger | · Nipro |
· B Braun | · Opsens Medical |
· Baylis Medical | · Oscor |
· BD | · PediaVascular |
· Becton Dickinson | · Penumbra |
· Biolife | · Philips |
· Biotronik | · Reflow Medical |
· Boston Scientific | · Rontis |
· Cardiovascular Systems | · Semler Technologies |
· Cardiva Medical | · ShockWave Medical |
· CeloNova | · Teleflex |
· Control Medical Technology | · Terumo |
· Conavi Medical | · Tricol Biomedical |
· Cook Medical | · Tryton Medical |
· Cordis | · TZ Medical |
· Galt Medical | · Z-Medica |
· Getinge |
List of Charts
Chart 1‑1: Interventional Cardiology Device Market by Segment, U.S., 2022 – 2029 |
Chart 1‑2: Interventional Cardiology Device Market Overview, U.S., 2022 & 2029 |
Chart 2‑1: Multi-Scenario Interventional Cardiology Device Market Forecast, U.S., 2019 – 2029 (US$M) |
Chart 5‑1: Interventional Cardiology Device Market by Segment, U.S., 2019 – 2029 |
Chart 5‑2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2022 |
Chart 6‑1: Interventional Cardiology Device Procedures by Segment, U.S., 2019 – 2029 |
Chart 7‑1: Coronary Stent Market by Segment, U.S., 2019 – 2029 |
Chart 7‑9: Leading Competitors, Coronary Stent Market, U.S., 2022 |
Chart 8‑1: Coronary Balloon Catheter Market by Segment, U.S., 2019 – 2029 |
Chart 8‑9: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2022 |
Chart 9‑1: Balloon-Inflation Device Market, U.S., 2019 – 2029 |
Chart 9‑2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2022 |
Chart 10‑1: Interventional Coronary Catheter Market by Segment, U.S., 2019 – 2029 |
Chart 10‑8: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2022 |
Chart 9‑1: Interventional Coronary Guidewire Market, U.S., 2019 – 2029 |
Chart 9‑2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2022 |
Chart 9‑1: Coronary Embolic Protection Device Market, U.S., 2019 – 2029 |
Chart 9‑2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2022 |
Chart 13‑1: Coronary Atherectomy Device Market by Segment, U.S., 2019 – 2029 |
Chart 13‑7: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2022 |
Chart 9‑1: Coronary Thrombectomy Device Market, U.S., 2019 – 2029 |
Chart 9‑2: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2022 |
Chart 15‑1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2019 – 2029 |
Chart 15‑7: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2022 |
Chart 16‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029 |
Chart 16‑10: Leading Competitors, Introducer Sheath Market, U.S., 2022 |
Chart 17‑1: Coronary Vascular Closure Device Market by Segment, U.S., 2019 – 2029 |
Chart 17‑10: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2022 |
Chart 18‑1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2019 – 2029 |
Chart 18‑7: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2022 |
Chart 19‑1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2019 – 2029 |
Chart 19‑6: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2022 |
Chart 19‑1 Coronary Optical Coherence Tomography Market by Segment, U.S., 2019 – 2029 |
Chart 19‑6: Leading Competitors, Coronary Optical Coherence Tomography Market, U.S., 2022 |
List of Figures
Figure 1‑1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2022 (1 of 3) |
Figure 1‑1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2022 (2 of 3) |
Figure 1‑1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2022 (3 of 3) |
Figure 1‑2: Companies Researched in this Report |
Figure 1‑3: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (1 of 3) |
Figure 1‑3: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (2 of 3) |
Figure 1‑3: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (3 of 3) |
Figure 1‑4: Recent Events in the Interventional Cardiology Device Market, U.S., 2019 – 2022 |
Figure 1‑5: Interventional Cardiology Device Procedures Covered |
Figure 1‑6: Procedure Codes Investigated |
Figure 1‑7: Interventional Cardiology Device Markets Covered |
Figure 1‑8: Key Report Updates |
Figure 1‑9: Version History |
Figure 2‑1: Interventional Cardiology Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑1: Interventional Cardiology Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑2: Interventional Cardiology Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑2: Interventional Cardiology Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑3: Interventional Cardiology Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑3: Interventional Cardiology Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 5‑1: Interventional Cardiology Device Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 5‑1: Interventional Cardiology Device Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 5‑2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2022 (1 of 2) |
Figure 5‑2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2022 (2 of 2) |
Figure 6‑1: Procedure Codes Investigated, U.S., 2022 |
Figure 6‑2: Interventional Cardiology Device Procedures by Segment, U.S., 2019 – 2029 |
Figure 6‑3: Angiography Procedures, U.S., 2019 – 2029 |
Figure 6‑4: Angiography Procedures by Approach, U.S., 2019 – 2029 |
Figure 6‑5: Angiography Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑6: Angioplasty/PCI Procedures, U.S., 2019 – 2029 |
Figure 6‑7: Angioplasty/PCI Procedures by Approach, U.S., 2019 – 2029 |
Figure 6‑8: Angiography/PCI Procedures by Modality, U.S., 2019 – 2029 |
Figure 6‑9: Angioplasty/PCI Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑10: Angiography/PCI Procedures by Imaging Technique, U.S., 2019 – 2029 |
Figure 6‑11: Coronary Atherectomy Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑11: Coronary Chronic Total Occlusion (CTO) Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑12: Catheterization Procedures by Setting, U.S., 2019 – 2029 |
Figure 7‑1: Coronary Stent Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 7‑2: Total Coronary Stent Market, U.S., 2019 – 2029 |
Figure 7‑3: Bare-Metal Stent Market, U.S., 2019 – 2029 |
Figure 7‑4: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
Figure 7‑5: Covered Stent Market, U.S., 2019 – 2029 |
Figure 7‑6: Bifurcated Stent Market, U.S., 2019 – 2029 |
Figure 7‑7: Coronary Stent Units Sold by Diameter, U.S., 2022 |
Figure 7‑8: Coronary Stent Units Sold by Diameter, U.S., 2022 |
Figure 7‑10: Leading Competitors, Coronary Stent Market, U.S., 2022 |
Figure 8‑1: Coronary Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 8‑2: Total Coronary Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑3: PTCA Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑4: Specialty Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 8‑5: Total Specialty Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑6: Cutting Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑7: Scoring Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑6: Drug-Eluting Balloon Catheter Market, U.S., 2019 – 2029 |
Figure 8‑8: Coronary Balloon Catheter Units Sold by Classification, U.S., 2022 |
Figure 8‑9: Coronary Balloon Catheter Units Sold by Indication, U.S., 2022 |
Figure 8‑11: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2022 |
Figure 9‑1: Balloon-Inflation Device Market, U.S., 2019 – 2029 |
Figure 9‑2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2022 |
Figure 10‑1: Interventional Coronary Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 10‑2: Total Interventional Coronary Catheter Market, U.S., 2019 – 2029 |
Figure 10‑3: Guiding Catheter Market, U.S., 2019 – 2029 |
Figure 10‑4: Extension Guide Catheter Market, U.S., 2019 – 2029 |
Figure 10‑5: Microcatheter Market by Segment, U.S., 2019 – 2029 |
Figure 10‑5: Microcatheter Market, U.S., 2019 – 2029 |
Figure 10‑5: Traditional Coronary Microcatheter Market by Segment, U.S., 2019 – 2029 |
Figure 10‑5: Traditional Coronary Microcatheter Market, U.S., 2019 – 2029 |
Figure 10‑4: Torquable Traditional Coronary Microcatheter Market, U.S., 2019 – 2029 |
Figure 10‑4: Braided Traditional Coronary Microcatheter Market, U.S., 2019 – 2029 |
Figure 10‑4: Dual-Lumen Specialty Coronary Microcatheter Market, U.S., 2019 – 2029 |
Figure 10‑7: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2022 |
Figure 9‑1: Interventional Coronary Guidewire Market, U.S., 2019 – 2029 |
Figure 9‑2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2022 |
Figure 9‑1: Coronary Embolic Protection Device Market, U.S., 2019 – 2029 |
Figure 9‑2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2022 |
Figure 13‑1: Coronary Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 13‑2: Total Coronary Atherectomy Device Market, U.S., 2019 – 2029 |
Figure 13‑3: Mechanical Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 13‑4: Laser Atherectomy Device Market, U.S., 2019 – 2029 |
Figure 13‑6: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2022 |
Figure 9‑1: Coronary Thrombectomy Device Market, U.S., 2019 – 2029 |
Figure 9‑2: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2022 |
Figure 15‑1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 15‑2: CTO Guidewire Market, U.S., 2019 – 2029 |
Figure 15‑3: CTO Catheter Market, U.S., 2019 – 2029 |
Figure 15‑4: CTO Device Market, U.S., 2019 – 2029 |
Figure 15‑6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2022 |
Figure 16‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 16‑2: Total Introducer Sheath Market, U.S., 2019 – 2029 |
Figure 16‑3: Standard Introducer Sheath Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 16‑4: Micro-Introducer Sheath Market, U.S., 2019 – 2029 |
Figure 16‑5: Introducer Sheath Market by Approach, U.S., 2019 – 2029 |
Figure 16‑6: Femoral Introducer Sheath Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 16‑7: Radial Introducer Sheath Market, U.S., 2019 – 2029 |
Figure 16‑9: Leading Competitors, Introducer Sheath Market, U.S., 2022 |
Figure 17‑1: Coronary Vascular Closure Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 17‑2: Total Coronary Vascular Closure Device Market, U.S., 2019 – 2029 |
Figure 17‑3: Invasive VCD Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 17‑4: Non-Invasive VCD Market by Segment, U.S., 2019 – 2029 |
Figure 17‑5: Total Non-Invasive VCD Market, U.S., 2019 – 2029 |
Figure 17‑6: Topical Hemostat Market, U.S., 2019 – 2029 |
Figure 17‑7: Radial Compression Band Market, U.S., 2019 – 2029 |
Figure 17‑8: Femoral Compression Band Market, U.S., 2019 – 2029 |
Figure 17‑10: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2022 |
Figure 18‑1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 18‑2: Diagnostic Coronary Guidewire Market, U.S., 2019 – 2029 |
Figure 18‑3: Diagnostic Coronary Catheter Market, U.S., 2019 – 2029 |
Figure 18‑4: FFR Guidewire Market, U.S., 2019 – 2029 |
Figure 18‑5: Penetration Rate, Fractional Flow Reserve Guidewire Market, U.S., 2019 – 2029 |
Figure 18‑7: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2022 |
Figure 19‑1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 19‑2: IVUS Catheter Market, U.S., 2019 – 2029 (US$M) |
Figure 19‑3: IVUS Console Market, U.S., 2019 – 2029 |
Figure 19‑5: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2022 |
Figure 19‑1: Coronary Optical Coherence Tomography Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 19‑2: OCT Catheter Market, U.S., 2019 – 2029 (US$M) |
Figure 19‑3: OCT Console Market, U.S., 2019 – 2029 |
Figure 19‑5: Leading Competitors, Coronary Optical Coherence Tomography Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
Report Summary | FREE |
Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | United States | 2023–2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market, Introducer Sheath Market, and 12 more
$7,995 – $9,995
iData’s U.S. interventional cardiology MedSuite covers 12 markets including the coronary stent and introducer sheath markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
- 2023
- 10 Years
- United States
- 01/06/2023
- 442
- MedSuite



